Email ID
Password
Sign me in automatically next time
clinica
RECENT TWEETS    
31 March 2015

 
30 March 2015
Poland’s first life sciences-dedicated venture capital fund was launched last week, with $42m in the coffers to invest in early and mid-stage companies. The Joint Polish Investment Fund (JPIF) is led by a team of four partners with track records in ...
30 March 2015
Details of plans to support an EU joint competent authority market surveillance project are gradually emerging from the European Commission. The commission has confirmed to Clinica that it has received an application for funding concerning a joint ...
27 March 2015
What should companies do if their notified body is de-designated or loses its status in their product area? Bassil Akra, of TŰV-SŰD Product Service, explained to Clinica what the options are in three different situations The current European ...
27 March 2015
Plans to introduce benefit assessments for new high-risk medical technology diagnosis and treatment methods (NUBs) in Germany have put the industry on its guard. A public hearing of the sickness insurance care bill ( Gesetz zur Stärkung der ...
 
30 March 2015
It has been a tough couple of years for robotic surgery specialist Intuitive Surgical, but the firm could be turning the corner, believes Jefferies analyst Imron Zafar. In its core US markets, the volume of prostate surgeries seem to have stabilized ...
27 March 2015
Johnson & Johnson has joined the list of healthcare’s big hitters that are partnering up with technology giant Google, this time to develop surgical robotics. J&J’s Ethicon surgical division has definitively agreed to collaborate with Google and ...
27 March 2015
Medtronic has made its second acquisition of 2015, purchasing hearing implant developer Sophono for an undisclosed fee. The Boulder, Colorado-based company, which specializes in magnetic, minimally-invasive, low-profile hearing implants, will join ...
26 March 2015
The South Korean government is to invest a total of KRW340bn ($305.4m) in 2015 to support and nurture stem cell and gene therapy firms, in a bid to gain a stronger position in these sectors The move also comes against a background of recent decisive ...
 
30 March 2015
Poland’s first life sciences-dedicated venture capital fund was launched last week, with $42m in the coffers to invest in early and mid-stage companies. The Joint Polish Investment Fund (JPIF) is led by a team of four partners with track records in ...
27 March 2015
Johnson & Johnson has joined the list of healthcare’s big hitters that are partnering up with technology giant Google, this time to develop surgical robotics. J&J’s Ethicon surgical division has definitively agreed to collaborate with Google and ...
27 March 2015
Medtronic has made its second acquisition of 2015, purchasing hearing implant developer Sophono for an undisclosed fee. The Boulder, Colorado-based company, which specializes in magnetic, minimally-invasive, low-profile hearing implants, will join ...
26 March 2015
French spinal technology firm Vexim has seen good growth since it went public in 2012, and is expecting to break even by the end of 2015. CEO Vincent Gardès spoke to Clinica soon after the company reported 69% sales expansion in 2014, to €10.3m ...
 
30 March 2015
Details of plans to support an EU joint competent authority market surveillance project are gradually emerging from the European Commission. The commission has confirmed to Clinica that it has received an application for funding concerning a joint ...
30 March 2015
Over the first three months of 2015, EU regulatory issues have continued to dominate the top three stories read by Clinica subscribers. But Japan is also a key market of interest. There is a great deal of change going on in Japan, after the ...
27 March 2015
What should companies do if their notified body is de-designated or loses its status in their product area? Bassil Akra, of TŰV-SŰD Product Service, explained to Clinica what the options are in three different situations The current European ...
27 March 2015
Plans to introduce benefit assessments for new high-risk medical technology diagnosis and treatment methods (NUBs) in Germany have put the industry on its guard. A public hearing of the sickness insurance care bill ( Gesetz zur Stärkung der ...
 
Ex-GE CEO Horgan to lead Align Technology Align Technologies, maker of the Invisalign dental brace, will soon be led by ex-GE Healthcare CEO Joseph Horgan. Mr Horgan will take up the reins on ...
Avedro gets a VC on board As Avedro awaits US FDA approval of its drug-device product for treating complications from refractive surgery, the Massachusetts firm has appointed ...
MitraClip pioneer Ferolyn Powell dies in motorbike accident Ferolyn Powell, best known for leading MitraClip developer Evalve, has died in a motorbike accident while on holidayin Thailand. Ms Powell oversaw ...
24 March 2015
Ashley Yeo

German health minister Hermann Gröhe will use his country’s presidency of the G7 to push new ideas on combating hospital-acquired infection (HAI) and antimicrobial resistance issues when the seven member states meet for their annual summit at ...

17 March 2015
Ashley Yeo

Post-recession and pre-election, the UK in spring 2015 is a land of promise, or at least promises, as far as the adoption of healthcare innovation is concerned. Last week’s official announcement of the Innovative Medicines and Medical Technology ...

 
24 March 2015
Ashley Yeo

German health minister Hermann Gröhe will use his country’s presidency of the G7 to push new ideas on combating hospital-acquired infection (HAI) and antimicrobial resistance issues when the seven member states meet for their annual summit at ...

17 March 2015
Ashley Yeo

Post-recession and pre-election, the UK in spring 2015 is a land of promise, or at least promises, as far as the adoption of healthcare innovation is concerned. Last week’s official announcement of the Innovative Medicines and Medical Technology ...

10 March 2015
Michael Scholl, Karl-Hubertus Gruber, Michael Marquardt

Michael Scholl, Karl-Hubertus Gruber and Michael Marquardt* offer a step-by-step guide for medtech companies on how to scale past the sales plateau and move towards continued growth Many mid-sized medtech companies are confronted with a growth ...

 
21 January 2015
Madeleine Armstrong

Liquid biopsies have shown great promise in detecting and monitoring cancer. One contender, Trovagene, tells Clinica why it believes it has the edge over other companies in the space One of the current goals in oncology is monitoring cancer “from ...

 
“Beyond Compliance”: a self regulation tool to add strength to the CE marking – podcast
16 December 2013
Get the Flash Player to see this player.
 

22 October 2014
Amanda Maxwell

The future regulation of high-risk devices is one of the trickiest subjects in the proposed EU Medical Device Regulation (MDR) on which to reach final agreement, with the different parties involved seemingly at loggerheads. Delegates at the European ...

 
31 May 2012
Hua Gong

Cancer diagnostics provide a promising future for unraveling the mystery of one of the leading killer diseases and helping to better detect and treat it. However, companies are currently facing a number of potential challenges when developing cancer ...

 
19 March 2015

Advanced MR Analytics (AMRA) Specialty area(s): MRI-based fat and muscle composition analysis Based in: Linköping, Sweden Founded in: 2012 No. of employees: 18 Total investment received to date: Around SEK15m ($1.7m) Investors: Industrifonden ...

 
24 November 2011
Phil Greenfield

Clinica’s Patent Watch focuses on key growth areas of regenerative medicine, or where there is potential to selectively treat disease with drugs in personalised treatments, as is the case with emerging areas of drug delivery and molecular ...

 
 
 
© 2015 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36